Ligand Pharmaceuticals Incorporated LGND

US Pharmaceuticals

$319.66 ▲ +1.75% (+$5.51)

⬆️ Above Yest. High ⚡ High Volume

Open $312.09

Prev Close $314.15

Day Range $310.41 – $320.62

52W Range $175.89 – $326.63

Market Cap $6.12B

P/E (TTM) 119.02

Beta 1.28

EPS (TTM) $2.29

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1992-11-18
Shares Out.	20,000,000
Website	ligand.com ↗
Phone	18585507500
Employees	47
Revenue	$78.7M
Gross Profit	$65.9M
Net Income	-$28.5M
Free Cash Flow	$90.6M
Total Assets	$2.24B
Total Liabilities	$1.28B
Equity	$961.8M

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Ligand Pharmaceuticals Incorporated is a publicly traded company under the ticker symbol LGND on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.